Literature DB >> 20504948

Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.

Suwen Wei1, Sayan Nandi, Violeta Chitu, Yee-Guide Yeung, Wenfeng Yu, Minmei Huang, Lewis T Williams, Haishan Lin, E Richard Stanley.   

Abstract

CSF-1 is broadly expressed and regulates macrophage and osteoclast development. The action and expression of IL-34, a novel CSF-1R ligand, were investigated in the mouse. As expected, huIL-34 stimulated macrophage proliferation via the huCSF-1R, equivalently to huCSF-1, but was much less active at stimulating mouse macrophage proliferation than huCSF-1. Like muCSF-1, muIL-34 and a muIL-34 isoform lacking Q81 stimulated mouse macrophage proliferation, CSF-1R tyrosine phosphorylation, and signaling and synergized with other cytokines to generate macrophages and osteoclasts from cultured progenitors. However, they respectively possessed twofold and fivefold lower affinities for the CSF-1R and correspondingly, lower activities than muCSF-1. Furthermore, muIL-34, when transgenically expressed in a CSF-1-dependent manner in vivo, rescued the bone, osteoclast, tissue macrophage, and fertility defects of Csf1(op)/(op) mice, suggesting similar regulation of CSF-1R-expressing cells by IL-34 and CSF-1. Whole-mount IL34 in situ hybridization and CSF-1 reporter expression revealed that IL34 mRNA was strongly expressed in the embryonic brain at E11.5, prior to the expression of Csf1 mRNA. QRT-PCR revealed that compared with Csf1 mRNA, IL34 mRNA levels were lower in pregnant uterus and in cultured osteoblasts, higher in most regions of the brain and heart, and not compensatorily increased in Csf1(op/op) mouse tissues. Thus, the different spatiotemporal expression of IL-34 and CSF-1 allows for complementary activation of the CSF-1R in developing and adult tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504948      PMCID: PMC2924605          DOI: 10.1189/jlb.1209822

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  46 in total

1.  Whole-mount in situ hybridization and detection of RNAs in vertebrate embryos and isolated organs.

Authors:  Anne Pizard; Anna Haramis; Andrés E Carrasco; Paula Franco; Silvia López; Alejandra Paganelli
Journal:  Curr Protoc Mol Biol       Date:  2004-05

2.  Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.

Authors:  T Tsurukai; N Udagawa; K Matsuzaki; N Takahashi; T Suda
Journal:  J Bone Miner Metab       Date:  2000       Impact factor: 2.626

3.  Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene.

Authors:  Mamoru Igarashi; Yoshiko Yogiashi; Masatomo Mihara; Ichiro Takada; Hirochika Kitagawa; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

4.  Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice.

Authors:  Violeta Chitu; Polly J Ferguson; Rosalie de Bruijn; Annette J Schlueter; Luis A Ochoa; Thomas J Waldschmidt; Yee-Guide Yeung; E Richard Stanley
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

5.  Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products.

Authors:  Valerie Garceau; Jacqueline Smith; Ian R Paton; Megan Davey; Mario A Fares; David P Sester; David W Burt; David A Hume
Journal:  J Leukoc Biol       Date:  2010-01-05       Impact factor: 4.962

6.  Origin of the lamina propria dendritic cell network.

Authors:  Milena Bogunovic; Florent Ginhoux; Julie Helft; Limin Shang; Daigo Hashimoto; Melanie Greter; Kang Liu; Claudia Jakubzick; Molly A Ingersoll; Marylene Leboeuf; E Richard Stanley; Michel Nussenzweig; Sergio A Lira; Gwendalyn J Randolph; Miriam Merad
Journal:  Immunity       Date:  2009-09-10       Impact factor: 31.745

7.  CSF-1 receptor structure/function in MacCsf1r-/- macrophages: regulation of proliferation, differentiation, and morphology.

Authors:  Wenfeng Yu; Jian Chen; Ying Xiong; Fiona J Pixley; Xu-Ming Dai; Yee-Guide Yeung; E Richard Stanley
Journal:  J Leukoc Biol       Date:  2008-06-17       Impact factor: 4.962

8.  Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.

Authors:  Haishan Lin; Ernestine Lee; Kevin Hestir; Cindy Leo; Minmei Huang; Elizabeth Bosch; Robert Halenbeck; Ge Wu; Aileen Zhou; Dirk Behrens; Diane Hollenbaugh; Thomas Linnemann; Minmin Qin; Justin Wong; Keting Chu; Stephen K Doberstein; Lewis T Williams
Journal:  Science       Date:  2008-05-09       Impact factor: 47.728

9.  Colony stimulating factor-1 dependence of paneth cell development in the mouse small intestine.

Authors:  Duy Huynh; Xu-Ming Dai; Sayan Nandi; Sally Lightowler; Melanie Trivett; Chee-Kai Chan; Ivan Bertoncello; Robert G Ramsay; E Richard Stanley
Journal:  Gastroenterology       Date:  2009-03-18       Impact factor: 22.682

10.  Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption.

Authors:  Wei Zou; Hideki Kitaura; Jennifer Reeve; Fanxin Long; Victor L J Tybulewicz; Sanford J Shattil; Mark H Ginsberg; F Patrick Ross; Steven L Teitelbaum
Journal:  J Cell Biol       Date:  2007-03-12       Impact factor: 10.539

View more
  154 in total

1.  Gab2 promotes colony-stimulating factor 1-regulated macrophage expansion via alternate effectors at different stages of development.

Authors:  Angel W Lee; Yingwei Mao; Josef M Penninger; Soojie Yu
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia.

Authors:  Yaming Wang; Kristy J Szretter; William Vermi; Susan Gilfillan; Cristina Rossini; Marina Cella; Alexander D Barrow; Michael S Diamond; Marco Colonna
Journal:  Nat Immunol       Date:  2012-06-24       Impact factor: 25.606

3.  Transplant tolerance: a new role for IL-34.

Authors:  James I Kim; Laurence A Turka
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

Review 4.  Macrophage polarization in pathology.

Authors:  Antonio Sica; Marco Erreni; Paola Allavena; Chiara Porta
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

Review 5.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

6.  IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.

Authors:  Yukihiro Wada; Hilda M Gonzalez-Sanchez; Julia Weinmann-Menke; Yasunori Iwata; Amrendra K Ajay; Myriam Meineck; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2019-01-08       Impact factor: 10.121

7.  IL-34 is a Treg-specific cytokine and mediates transplant tolerance.

Authors:  Séverine Bézie; Elodie Picarda; Jason Ossart; Laurent Tesson; Claire Usal; Karine Renaudin; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

8.  Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).

Authors:  Violeta Chitu; Solen Gokhan; Maria Gulinello; Craig A Branch; Madhuvati Patil; Ranu Basu; Corrina Stoddart; Mark F Mehler; E Richard Stanley
Journal:  Neurobiol Dis       Date:  2014-12-09       Impact factor: 5.996

9.  Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor.

Authors:  Chao Zhang; Prabha N Ibrahim; Jiazhong Zhang; Elizabeth A Burton; Gaston Habets; Ying Zhang; Ben Powell; Brian L West; Bernice Matusow; Garson Tsang; Rafe Shellooe; Heidi Carias; Hoa Nguyen; Adhirai Marimuthu; Kam Y J Zhang; Angela Oh; Ryan Bremer; Clarence R Hurt; Dean R Artis; Guoxian Wu; Marika Nespi; Wayne Spevak; Paul Lin; Keith Nolop; Peter Hirth; Greg H Tesch; Gideon Bollag
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

10.  Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy.

Authors:  Rikke B Holmgaard; Alexandra Brachfeld; Billel Gasmi; David R Jones; Marissa Mattar; Thompson Doman; Mary Murphy; David Schaer; Jedd D Wolchok; Taha Merghoub
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.